
Kingsdale Advisors is pleased to announce its role as a strategic advisor in the Canada M&A Deal of the Year, recognized at the 16th Americas M&A Atlas Awards annual gala.
The award recognizes the successful merger between biopharmaceutical company Aeterna Zentaris and biotechnology company Ceapro. The transaction, a significant cross-border deal, highlights Kingsdale’s expertise in proxy advisory, governance advisory, data and engagement, and strategic communications — all critical components in achieving this milestone.
For 22 years, business leaders have relied on Kingsdale to navigate complex transactions and defend against shareholder activism. With offices in Toronto, Calgary, and New York, Kingsdale continues to be the most trusted shareholder and governance advisory firm in Canada, providing unparalleled expertise in M&A advisory, corporate governance, and strategic shareholder engagement.
Neil Tolentino, Vice President, Strategic Advisory and Analytics, and Raman Bhan, Vice President, Operations, played critical roles in leading their teams to successfully engage shareholders to vote for the transaction.
This recognition underscores Kingsdale’s commitment to excellence and its role as a leader in the evolving corporate landscape.

Latest Insights
2025 Proxy Season: Kingsdale Delivers 100% Win Rate
Kingsdale achieved a perfect track record for clients navigating shareholder activism and other special situations. The firm also advised on more than C$22 billion in shareholder approved or completed M&A transactions year-to-date.
M&A Case Study: How One Dissenting Shareholder Nearly Derailed a $201M Acquisition
What started as a straightforward acquisition of Payfare by Fiserv quickly turned complicated when a major shareholder decided to block the deal. With the transaction hanging in the balance, here's what it took to get 80% approval.
ISS 2026 Benchmark Policy Updates: What You Need to Know
ISS has announced updates to its 2026 Benchmark Policies, spotlighting long-term pay-for-performance alignment, enhanced scrutiny on director compensation, and a global push toward harmonization. These changes signal a clear trend: investors expect durability, transparency, and strategic disclosure.

When The Stakes Are Highest, Business Leaders Choose Kingsdale
Subscribe to Our Newsletter
* Source: Bloomberg Global Shareholder Activism League Tables FY2025 and LSEG Global Shareholder Activism Review FY2025.
#2025 and 2026 indicate proxy seasons: July 2024 to June 2026.
